NEUEHEALTH INC (NEUE) Stock Price, Quote, News and Overview
NYSE:NEUE - New York Stock Exchange, Inc. - US10920V4041 - Common Stock - Currency: USD
NEUE Quote, Performance and Key Statistics
NYSE:NEUE (5/23/2025, 8:40:25 PM)
6.75
-0.13 (-1.89%)
The current stock price of NEUE is 6.75 USD. In the past month the price decreased by -0.74%. In the past year, price increased by 13.45%.
NEUE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 10.57 | 268.12B | ||
| ELV | ELEVANCE HEALTH INC | 10.85 | 84.11B | ||
| CNC | CENTENE CORP | 7.29 | 28.07B | ||
| HUM | HUMANA INC | 10.95 | 27.15B | ||
| MOH | MOLINA HEALTHCARE INC | 13.27 | 16.54B | ||
| HQY | HEALTHEQUITY INC | 31.63 | 8.58B | ||
| ALHC | ALIGNMENT HEALTHCARE INC | N/A | 2.86B | ||
| PGNY | PROGYNY INC | 36 | 1.76B | ||
| CLOV | CLOVER HEALTH INVESTMENTS CO | N/A | 1.62B |
Related stock screener links
About NEUE
Company Profile
NeueHealth, Inc. engages in the provision of healthcare products and services for consumers and care providers in local markets. The company is headquartered in Doral, Florida and currently employs 986 full-time employees. The company went IPO on 2021-06-24. The Company’s segments include NeueCare and NeueSolutions. The NeueCare segment is a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across the Affordable Care Act (ACA) Marketplace, Medicare, and Medicaid. NeueCare delivers in-person and virtual clinical care through its 66-owned primary care clinics within an integrated care delivery system. Its integrated system of care includes embedded pharmacy, laboratory, radiology, and population health focused specialty services. The company offers consumers providing primary care, behavioral health, rotating specialties, pharmacy, radiology, and laboratory services, many times at a single location. The NeueSolutions segment is a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers. NeueSolutions serves approximately 42,000 value-based care consumers.
Company Info
NEUEHEALTH INC
9250 Nw 36Th Street, Suite 420
Doral FLORIDA US
Employees: 1252
Phone: 16122381321
NEUEHEALTH INC / NEUE FAQ
What is the stock price of NEUEHEALTH INC today?
The current stock price of NEUE is 6.75 USD. The price decreased by -1.89% in the last trading session.
What is the ticker symbol for NEUEHEALTH INC stock?
The exchange symbol of NEUEHEALTH INC is NEUE and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is NEUE stock listed?
NEUE stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for NEUEHEALTH INC stock?
7 analysts have analysed NEUE and the average price target is 7.14 USD. This implies a price increase of 5.78% is expected in the next year compared to the current price of 6.75. Check the NEUEHEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is NEUEHEALTH INC worth?
NEUEHEALTH INC (NEUE) has a market capitalization of 60.28M USD. This makes NEUE a Micro Cap stock.
How many employees does NEUEHEALTH INC have?
NEUEHEALTH INC (NEUE) currently has 1252 employees.
What are the support and resistance levels for NEUEHEALTH INC (NEUE) stock?
NEUEHEALTH INC (NEUE) has a support level at 6.13 and a resistance level at 6.8. Check the full technical report for a detailed analysis of NEUE support and resistance levels.
Is NEUEHEALTH INC (NEUE) expected to grow?
The Revenue of NEUEHEALTH INC (NEUE) is expected to decline by -26.98% in the next year. Check the estimates tab for more information on the NEUE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NEUEHEALTH INC (NEUE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NEUE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NEUE, evaluating the profitability, health, valuation and growth aspects
- NEUEHEALTH INC (NEUE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NEUEHEALTH INC (NEUE) Sales and EPS estimates to see what analysts future expectations are.
- NEUEHEALTH INC (NEUE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NEUEHEALTH INC (NEUE) Insider and Institutional Ownership to learn about the owners and their transactions.
- NEUEHEALTH INC (NEUE) Stock Chart to make your own analysis
- NEUEHEALTH INC (NEUE) Latest news and press-releases to stay up to date.
Does NEUEHEALTH INC (NEUE) stock pay dividends?
NEUE does not pay a dividend.
When does NEUEHEALTH INC (NEUE) report earnings?
NEUEHEALTH INC (NEUE) will report earnings on 2025-08-05.
What is the Price/Earnings (PE) ratio of NEUEHEALTH INC (NEUE)?
NEUEHEALTH INC (NEUE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-11.75).
What is the Short Interest ratio of NEUEHEALTH INC (NEUE) stock?
The outstanding short interest for NEUEHEALTH INC (NEUE) is 0.06% of its float. Check the ownership tab for more information on the NEUE short interest.
NEUE Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to NEUE. When comparing the yearly performance of all stocks, NEUE turns out to be only a medium performer in the overall market: it outperformed 66.06% of all stocks.
NEUE Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to NEUE. NEUE may be in some trouble as it scores bad on both profitability and health.
NEUE Financial Highlights
Over the last trailing twelve months NEUE reported a non-GAAP Earnings per Share(EPS) of -11.75. The EPS decreased by -529172956216033500% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -20.4% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
NEUE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 46% to NEUE. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of -216.11% and a revenue growth -26.98% for NEUE